In tests jointly conducted with Aviation Clean Air, Global Plasma Solutions has demonstrated the effectiveness of its proprietary needlepoint bipolar ionisation technology to neutralise SARS-CoV-2 (COVID-19) on surfaces.
In the laboratory study, Aviation Clean Air designed a test to mimic ionisation conditions such as those of a commercial aircraft’s fuselage. Based on viral titrations, it was determined that at 10 minutes, 84.2% of the virus was inactivated. At 15 minutes, 92.6% of the virus was inactivated, and at 30 minutes, 99.4% of the virus was inactivated.
Needlepoint bipolar ionisation leverages an electronic charge to create a high concentration of positive and negative ions. These ions travel through the air continuously seeking out and attaching to particles. This sets in motion a continuous pattern of particle combination. As these particles become larger, they are eliminated from the air more rapidly.
Additionally, positive, and negative ions have microbicidal effects on pathogens, ultimately reducing the infectivity of the virus. Global Plasma Solutions’ needlepoint bipolar ionisation is ozone-free and the only kind in its category to pass the RCTA DO-160 standard for aircraft.
Traditional bipolar ionisation systems produce harmful ozone as a byproduct.
